New skin ulcer technology can treat diabetic foot ulcers

12/28/2012 | MedCityNews.com

Oculus Innovative Sciences has received a U.S. patent for its Microcyn Technology to be used in treating patients with diabetic foot ulcers. The technology is administered to skin ulcers either by irrigation, soaking and washing, or by applying a wound dressing that has been soaked with the technology.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health